Pulmonary Inflammatory Response in Lethal COVID-19 Reveals Potential Therapeutic Targets and Drugs in Phases III/IV Clinical Trials

 

Authors
López Cortés, Andrés; Guerrero, Santiago; Ortiz Prado, Esteban; Yumiceba, Verónica; Vera Guapi, Antonella; León Cáceres, Ángela; Simbaña Rivera, Katherine; Gómez Jaramillo, Ana María; Echeverría Garcés, Gabriela; García Cárdenas, Jennyfer M.; Puig San Andrés, Lourdes; Guevara Ramírez, Patricia; Cabrera Andrade, Alejandro; Bautista, Jhommara; Pérez Villa, Andy; Ramos Medin, María José; Pérez Meza, Álvaro Alexander; Nieto Jaramillo, Karol; Jácome, Andrea V.; Morillo, Andrea
Format
Article
Status
publishedVersion
Description

Publication Year
2022
Language
Topic
ulmonary inflammatory response
Clinical trials, drugs
Lethal COVID-19
Single nucleus RNA sequencing
Repository
Repositorio Universidad Regional Amazónica
Get full text
https://doi.org/10.3389/fphar.2022.833174
http://repositorio.ikiam.edu.ec/jspui/handle/RD_IKIAM/529
Rights
openAccess
License